Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
about
Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in MiceEvaluation of Efficacy and Safety of Dan'e-Fukang Soft Extract in the Treatment of Endometriosis: A Meta-Analysis of 39 Randomized Controlled Trials Enrolling 5442 PatientsNew insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.Diet-induced obesity impairs spermatogenesis: a potential role for autophagy.Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen).Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane.Emerging roles of SIRT1 in fatty liver diseases.HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells.Salidroside Inhibits HMGB1 Acetylation and Release through Upregulation of SirT1 during Inflammation.Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.CR6 interacting factor 1 deficiency promotes endothelial inflammation by SIRT1 downregulation.
P2860
Q28554444-5005DDC0-F0ED-475E-8FC0-96D355D02C71Q36321423-38675D50-6112-4EB5-9EDF-EC62A2F62AB1Q37040345-A433369F-1F7F-4A49-8E08-29768C631701Q37690389-5981593B-8CA9-41B0-A777-E6E4B8B46E20Q39353293-E564C9CE-50EA-4CA1-890D-03AE9EBD3E8AQ41334657-77B11CE4-5EE3-4140-81C5-AA752FDD28BEQ41377073-C67AC458-2F02-4F9E-8F02-1882E2132AB4Q41849354-A26F8E9A-AD1A-4A95-B06F-5E2A2DB9831BQ42140906-211F203D-1090-48E5-A2A3-AC475ED215ABQ47148987-E20EBB8F-3534-4777-A1B7-C0CEC86E1321Q48247117-82347D7B-72B6-48C5-9C81-9CAF5233E330Q48397481-77437F8B-68B7-4696-A360-A70A7B2FAAF9Q51748458-8362EEE0-7806-47C0-ABAB-2CC0D7ACACB5
P2860
Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@ast
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@en
type
label
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@ast
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@en
prefLabel
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@ast
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of HMGB1 release vi ...... alcoholic fatty liver disease.
@en
P2093
Dongyan Gao
Guangzhi Wang
Jihong Yao
Jinyong Peng
Ning Zhang
Wenjing Zeng
Xiaochi Ma
P2860
P2888
P356
10.1038/SREP16013
P407
P577
2015-11-03T00:00:00Z